Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York. more
Time Frame | PTIX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 23.41% | -2.06% | -0.55% |
1-Month Return | 10.71% | -1.92% | 2.72% |
3-Month Return | 2.57% | -10.4% | 7.66% |
6-Month Return | -33.12% | -4.6% | 10.15% |
1-Year Return | -19.75% | 4.06% | 27.53% |
3-Year Return | -89.91% | 1.94% | 32.31% |
5-Year Return | -91.97% | 36.48% | 89.2% |
10-Year Return | -99.69% | 97.46% | 194.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 339.00 | 286.00 | - | 30.00 | 28.22K | [{"date":"2019-12-31","value":1.2,"profit":true},{"date":"2020-12-31","value":1.01,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":0.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (339.00) | (286.00) | - | (30.00) | (28.22K) | [{"date":"2019-12-31","value":-33900,"profit":false},{"date":"2020-12-31","value":-28600,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3000,"profit":false},{"date":"2023-12-31","value":-2821800,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 2.09M | 2.55M | 4.14M | 3.56M | 4.53M | [{"date":"2019-12-31","value":46.08,"profit":true},{"date":"2020-12-31","value":56.36,"profit":true},{"date":"2021-12-31","value":91.46,"profit":true},{"date":"2022-12-31","value":78.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (2.09M) | (2.55M) | (4.14M) | (3.56M) | (4.53M) | [{"date":"2019-12-31","value":-208613000,"profit":false},{"date":"2020-12-31","value":-255161100,"profit":false},{"date":"2021-12-31","value":-414041300,"profit":false},{"date":"2022-12-31","value":-355778800,"profit":false},{"date":"2023-12-31","value":-452697400,"profit":false}] |
Total Non-Operating Income/Expense | 322.15K | (242.80K) | (846.23K) | 50.62K | (297.06K) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-75.37,"profit":false},{"date":"2021-12-31","value":-262.68,"profit":false},{"date":"2022-12-31","value":15.71,"profit":true},{"date":"2023-12-31","value":-92.21,"profit":false}] |
Pre-Tax Income | (1.75M) | (2.55M) | (4.52M) | (3.56M) | (5.00M) | [{"date":"2019-12-31","value":-175091100,"profit":false},{"date":"2020-12-31","value":-254873500,"profit":false},{"date":"2021-12-31","value":-452293400,"profit":false},{"date":"2022-12-31","value":-355550500,"profit":false},{"date":"2023-12-31","value":-500049700,"profit":false}] |
Income Taxes | 15.89K | 246.18K | 463.70K | 46.05K | 2.00 | [{"date":"2019-12-31","value":3.43,"profit":true},{"date":"2020-12-31","value":53.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.93,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (1.77M) | (2.79M) | (4.99M) | (3.60M) | (5.00M) | [{"date":"2019-12-31","value":-176679700,"profit":false},{"date":"2020-12-31","value":-279491300,"profit":false},{"date":"2021-12-31","value":-498663900,"profit":false},{"date":"2022-12-31","value":-360155600,"profit":false},{"date":"2023-12-31","value":-500049900,"profit":false}] |
Income From Continuous Operations | (1.75M) | (2.55M) | (4.52M) | (3.56M) | (3.93M) | [{"date":"2019-12-31","value":-175091100,"profit":false},{"date":"2020-12-31","value":-254873500,"profit":false},{"date":"2021-12-31","value":-452293400,"profit":false},{"date":"2022-12-31","value":-355550500,"profit":false},{"date":"2023-12-31","value":-392568700,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.77M) | (2.79M) | (4.99M) | (3.60M) | (5.00M) | [{"date":"2019-12-31","value":-176679700,"profit":false},{"date":"2020-12-31","value":-279491300,"profit":false},{"date":"2021-12-31","value":-498663900,"profit":false},{"date":"2022-12-31","value":-360155600,"profit":false},{"date":"2023-12-31","value":-500049700,"profit":false}] |
EPS (Diluted) | (0.16) | (0.30) | (0.32) | (0.28) | - | [{"date":"2019-12-31","value":-16.08,"profit":false},{"date":"2020-12-31","value":-30,"profit":false},{"date":"2021-12-31","value":-32,"profit":false},{"date":"2022-12-31","value":-28.27,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
PTIX | |
---|---|
Cash Ratio | 1.34 |
Current Ratio | 1.80 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PTIX | |
---|---|
ROA (LTM) | -90.17% |
ROE (LTM) | -206.36% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PTIX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.52 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.48 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PTIX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 5.29 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
PEG | NM |
Protagenic Therapeutics (PTIX) share price today is $0.642
Yes, Indians can buy shares of Protagenic Therapeutics (PTIX) on Vested. To buy Protagenic Therapeutics from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PTIX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Protagenic Therapeutics (PTIX) via the Vested app. You can start investing in Protagenic Therapeutics (PTIX) with a minimum investment of $1.
You can invest in shares of Protagenic Therapeutics (PTIX) via Vested in three simple steps:
The 52-week high price of Protagenic Therapeutics (PTIX) is $1.87. The 52-week low price of Protagenic Therapeutics (PTIX) is $0.45.
The price-to-earnings (P/E) ratio of Protagenic Therapeutics (PTIX) is
The price-to-book (P/B) ratio of Protagenic Therapeutics (PTIX) is 5.29
The dividend yield of Protagenic Therapeutics (PTIX) is 0.00%
The market capitalization of Protagenic Therapeutics (PTIX) is $4.04M
The stock symbol (or ticker) of Protagenic Therapeutics is PTIX